Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose David

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Diagnostics (Basel, Switzerland)|January 11, 2024
Validity of the Espiro Mobile Application in the Interpretation of Spirometric Patterns: An App Accuracy StudyDarinka Savic-Pesic, Nuria Chamorro, Vanesa Lopez-Rodriguez, et al.
The Lancet. Oncology|July 7, 2022
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trialRobin Kate Kelley, Lorenza Rimassa, Ann-Lii Cheng, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 9, 2021
Chronodisruption and diet associated with increased cardiometabolic risk in coronary heart disease patients: the CORDIOPREV studyJuan Luis Romero-Cabrera, Marta Garaulet, Jose Jimenez-Torres, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2024
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 studyThomas Yau, Ahmed Kaseb, Ann-Lii Cheng, et al.
Research Square|January 3, 2024
Reducing Time to Diagnosis of Rare Genetic Diseases in a Medically Underserved Hispanic Population- Lessons Learned for Meaningful EngagementBlake Vuocolo, Roberta Sierra, Dan Brooks, et al.
Journal of Neurodevelopmental Disorders|September 9, 2024
Project GIVE: using a virtual genetics service platform to reduce health inequities and improve access to genomic care in an underserved region of TexasBlake Vuocolo, Roberta Sierra, Daniel Brooks, et al.
European Journal of Nutrition|July 26, 2019
Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trialGracia Maria Quintana-Navarro, Juan Francisco Alcala-Diaz, Javier Lopez-Moreno, et al.
International Journal of Cardiology|November 21, 2025
TRI·Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repairAntonio Sisinni, Manuel Barreiro-Perez, Xavier Freixa, et al.
Scientific Reports|October 22, 2022
Impaired muscle strength is associated with ultrastructure damage in myositisAndrea Aguilar-Vazquez, Efrain Chavarria-Avila, Mario Salazar-Paramo, et al.
Journal of the American Heart Association|January 17, 2025
Real-World Experience in Tricuspid Transcatheter Edge-to-Edge Repair: Transcatheter Tricuspid Valve Repair in Spain RegistryAntonio Sisinni, Manuel Barreiro-Perez, Xavier Freixa, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Diagnostics (Basel, Switzerland)|January 11, 2024
Validity of the Espiro Mobile Application in the Interpretation of Spirometric Patterns: An App Accuracy StudyDarinka Savic-Pesic, Nuria Chamorro, Vanesa Lopez-Rodriguez, et al.
The Lancet. Oncology|July 7, 2022
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trialRobin Kate Kelley, Lorenza Rimassa, Ann-Lii Cheng, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|November 9, 2021
Chronodisruption and diet associated with increased cardiometabolic risk in coronary heart disease patients: the CORDIOPREV studyJuan Luis Romero-Cabrera, Marta Garaulet, Jose Jimenez-Torres, et al.
The Lancet. Gastroenterology & Hepatology|February 16, 2024
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 studyThomas Yau, Ahmed Kaseb, Ann-Lii Cheng, et al.
Research Square|January 3, 2024
Reducing Time to Diagnosis of Rare Genetic Diseases in a Medically Underserved Hispanic Population- Lessons Learned for Meaningful EngagementBlake Vuocolo, Roberta Sierra, Dan Brooks, et al.
Journal of Neurodevelopmental Disorders|September 9, 2024
Project GIVE: using a virtual genetics service platform to reduce health inequities and improve access to genomic care in an underserved region of TexasBlake Vuocolo, Roberta Sierra, Daniel Brooks, et al.
European Journal of Nutrition|July 26, 2019
Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trialGracia Maria Quintana-Navarro, Juan Francisco Alcala-Diaz, Javier Lopez-Moreno, et al.
International Journal of Cardiology|November 21, 2025
TRI·Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repairAntonio Sisinni, Manuel Barreiro-Perez, Xavier Freixa, et al.
Scientific Reports|October 22, 2022
Impaired muscle strength is associated with ultrastructure damage in myositisAndrea Aguilar-Vazquez, Efrain Chavarria-Avila, Mario Salazar-Paramo, et al.
Journal of the American Heart Association|January 17, 2025
Real-World Experience in Tricuspid Transcatheter Edge-to-Edge Repair: Transcatheter Tricuspid Valve Repair in Spain RegistryAntonio Sisinni, Manuel Barreiro-Perez, Xavier Freixa, et al.
Pageof 13